| 1 |
Tsao AS，Wistuba I，Roth JA，et al．Malignant pleural mesothelioma[J]．J Clin Oncol，2009，27（12）：2081-2090．
|
| 2 |
迟雨佳，刘奕良，赵军．胸膜间皮瘤免疫治疗研究进展[J]．中国肺癌杂志，2022，25（4）：259-265．
|
| 3 |
Carteni G，Manegold C，Garcia GM，et al．Malignant peritoneal mesothelioma-Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent[J]．Lung Cancer，2009，64（2）：211-218．
|
| 4 |
Mazurek JM，Syamlal G，Wood JM，et al．Malignant Mesothelioma Mortality - United States, 1999-2015[J]．MMWR Morb Mortal Wkly Rep，2017，66（8）：214-218．
|
| 5 |
van Zandwijk N，Clarke C，Henderson D，et al．Guidelines for the diagnosis and treatment of malignant pleural mesothelioma[J]．J Thorac Dis，2013，5（6）：E254-E307．
|
| 6 |
Kindler HL，Ismaila N，Armato SG 3rd，et al．Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline[J]．J Clin Oncol，2018，36（13）：1343-1373．
|
| 7 |
Henderson DW，Reid G，Kao SC，et al．Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers[J]．J Clin Pathol，2013，66（10）：847-853．
|
| 8 |
Sauter JL，Dacic S，Galateau-Salle F，et al．The 2021 WHO Classification of Tumors of the Pleura: Advances Since the 2015 Classification[J]．J Thorac Oncol，2022，17（5）：608-622．
|
| 9 |
Larson T，Melnikova N，Davis SI，et al．Incidence and descriptive epidemiology of mesothelioma in the United States, 1999-2002[J]．Int J Occup Environ Health，2007，13（4）：398-403．
|
| 10 |
Marchevsky AM，Khoor A，Walts AE，et al．Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma Panel[J]．Mod Pathol，2020，33（2）：281-296．
|
| 11 |
Hung YP，Dong F，Torre M，et al．Molecular characterization of diffuse malignant peritoneal mesothelioma[J]．Mod Pathol，2020，33（11）：2269-2279．
|
| 12 |
Thieke C，Nicolay NH，Sterzing F，et al．Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy[J]．Radiat Oncol，2015，10：267．
|
| 13 |
Amin MB, Greene FL, Byrd DR. AJCC Cancer Staging Manual, 8th edition: Springer International Publishing; 2017:1-1024.
|
| 14 |
Bölükbas S，Manegold C，Eberlein M，et al．Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy[J]．Lung Cancer，2011，71（1）：75-81．
|
| 15 |
Expert Panel on Thoracic Imaging，Bacchus L，Shah RD，et al．ACR Appropriateness Criteria Review ACR Appropriateness Criteria® Occupational Lung Diseases[J]．J Thorac Imaging，2016，31（1）：W1-W3．
|
| 16 |
Grossebner MW，Arifi AA，Goddard M，et al．Mesothelioma--VATS biopsy and lung mobilization improves diagnosis and palliation[J]．Eur J Cardiothorac Surg，1999，16（6）：619-623．
|
| 17 |
Kaufman AJ，Flores RM．Surgical treatment of malignant pleural mesothelioma[J]．Curr Treat Options Oncol，2011，12（2）：201-216．
|
| 18 |
Rice D，Rusch V，Pass H，et al．Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the international association for the study of lung cancer international staging committee and the international mesothelioma interest group[J]．J Thorac Oncol，2011，6（8）：1304-1312．
|
| 19 |
Bölükbas S，Eberlein M，Fisseler-Eckhoff A，et al．Radical pleurectomy and chemoradiation for malignant pleural mesothelioma: the outcome of incomplete resections[J]．Lung Cancer，2013，81（2）：241-246．
|
| 20 |
Furia S，Verderi E，Natale G，et al．The surgical-based treatment of malignant pleural mesothelioma: a literature review of a still ongoing debate[J/CD]．Chinese Journal of Thoracic Surgery （Electronic Edition），2022，9（4）：197-207．
|
| 21 |
Schipper PH，Nichols FC，Thomse KM，et al．Malignant pleural mesothelioma: surgical management in 285 patients[J]．Ann Thorac Surg，2008，85（1）：257-264．
|
| 22 |
Treasure T，Lang-Lazdunski L，Waller D，et al．Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study[J]．Lancet Oncol，2011，12（8）：763-772．
|
| 23 |
Weder W，Stahel RA，Baas P，et al．The MARS feasibility trial: conclusions not supported by data[J]．Lancet Oncol，2011，12（12）：1093-1094．
|
| 24 |
Cao C，Tian D，Park J，et al．A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma[J]．Lung Cancer，2014，83（2）：240-245．
|
| 25 |
Spaggiari L，Marulli G，Bovolato P，et al．Extrapleural pneumonectomy for malignant mesothelioma: an Italian multicenter retrospective study[J]．Ann Thorac Surg，2014，97（6）：1859-1865．
|
| 26 |
Nakas A，von Meyenfeldt E，Lau K，et al．Long-term survival after lung-sparing total pleurectomy for locally advanced （International Mesothelioma Interest Group Stage T3-T4）non-sarcomatoid malignant pleural mesothelioma[J]．Eur J Cardiothorac Surg，2012，41（5）：1031-1036．
|
| 27 |
Scherpereel A，Astoul P，Baas P，et al．Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma[J]．Eur Respir J，2010，35（3）：479-495．
|
| 28 |
Krug LM，Pass HI，Rusch VW，et al．Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma[J]．J Clin Oncol，2009，27（18）：3007-3013．
|
| 29 |
Srinivasan G，Sidhu GS，Williamson EA，et al．Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition[J]．Cancer Chemother Pharmacol，2017，80（4）：861-867．
|
| 30 |
Flores RM，Pass HI，Seshan VE，et al．Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients[J]．J Thorac Cardiovasc Surg，2008，135（3）：620-6，626.e1-3．
|